OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 66 filers reported holding OYSTER PT PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $133,705 | +99.6% | 11,970 | 0.0% | 0.04% | +111.1% |
Q3 2022 | $67,000 | +28.8% | 11,970 | 0.0% | 0.02% | +12.5% |
Q2 2022 | $52,000 | -62.6% | 11,970 | 0.0% | 0.02% | -50.0% |
Q1 2022 | $139,000 | -61.0% | 11,970 | -37.8% | 0.03% | -56.8% |
Q4 2021 | $356,000 | +150.7% | 19,230 | +60.7% | 0.07% | +124.2% |
Q3 2021 | $142,000 | -32.4% | 11,970 | +64.9% | 0.03% | -50.7% |
Q2 2020 | $210,000 | – | 7,260 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |